Loading…

OC65 Blood phytosterol levels in children with intestinal failure on home parenteral nutrition, and relation to liver disease

Intestinal failure-associated liver disease(IFALD) in children on parenteral nutrition(PN) probably has a multifactorial aetiology. In particular, soya lipid emulsion has been associated with accumulation of phytosterols and associated cholestatic liver disease.1 More recently mixed lipid emulsions...

Full description

Saved in:
Bibliographic Details
Published in:Frontline gastroenterology 2023-07, Vol.14 (Suppl 1), p.A40-A40
Main Authors: Abdelhafez, H, Gayda-Pimlott, D, Horn, V, Al-Araji, R, Koeglmeier, J, Hill, S
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page A40
container_issue Suppl 1
container_start_page A40
container_title Frontline gastroenterology
container_volume 14
creator Abdelhafez, H
Gayda-Pimlott, D
Horn, V
Al-Araji, R
Koeglmeier, J
Hill, S
description Intestinal failure-associated liver disease(IFALD) in children on parenteral nutrition(PN) probably has a multifactorial aetiology. In particular, soya lipid emulsion has been associated with accumulation of phytosterols and associated cholestatic liver disease.1 More recently mixed lipid emulsions which include fish, as well as soya, olive and coconut oil, >vitamin E and 6 months. Data collected included: age, gender, diagnosis (categorised as short bowel syndrome[SBS], motility disorder or intestinal mucosal disorder), years on PN, nights/week PN infused, nights/week with lipid, whether tolerating some oral/enteral nutrition and liver US. Blood results reviewed were phytosterol, albumin, liver enzyme(ALT, ALP, GGT), Vitamin A, E, D, clotting screen, and platelet levels.There were 29 children,16 female,13 male, aged 2–18 years. Eleven, 38%, had SBS, 9, 31% motility disorder and 9, 31% a mucosal disorder. Twenty-three, 79% tolerated some oral/enteral nutrition and 6, 21% did not.Eighteen patients, 62% were on PN since infancy. Patients had 3–7(mean 6.3) PN infusions/week, administered over 10–24(mean 13.5)hours, with lipid included from 0–5(mean 2.6) nights/week. The lipid used was SMOFlipid.Three patients, 10.3% had mildly elevated phytosterol levels, three, 10.3% borderline raised levels (within 10% of normal range) and 23, 79.3% had normal levels. One child on anti-fungal medication had a raised fungal related sterol, lanosterol. The elevated phytosterols in the three patients were:1. mild elevation of whole phytosterol profile2. raised Sitosterol and a cholesterol precursor level3. raised SitosterolTwo patients with high phytosterol levels had low blood albumen, 28g/l. Albumin was normal in the other 27 patients. ALT was normal in 27/29 patients and raised in 2/29(range 9–138U/L, median 28 U/L). Bilirubin was normal/borderline raised in all cases ranging from 2–20(median 8)umol/l. GGT ranged from 10–14(median 22) U/L. ALP ranged from 95–324U/L, median 202U/l. Vitamin A levels were 0.62–2.13(median 1.37) umol/L, Vitamin E was normal 11.5–46.4 umol/L in all 29 cases. Vitamin D was 33
doi_str_mv 10.1136/flgastro-2023-bspghan.64
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2842356512</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2842356512</sourcerecordid><originalsourceid>FETCH-proquest_journals_28423565123</originalsourceid><addsrcrecordid>eNqNjb1OBDEMhCMEEie4d7BEyx6bv4WaE4iOhv4UWO9tTiZe4uwhKmh4UZ6EICFq3Njj-UajFOh2pbXtLgbaBimZG9Ma2zzKtB1DWnXuQC1M63TjtPOHf7e9PFZLkV1bx1rtvVuo9_t1578-Pq-JuYdpfCssBTMTEO6RBGKCpzFSnzHBayxjfRSUElMgGEKkOSNwgpGfEaZQqZquVppLjiVyOoeQeshI4UdBYaC4xwx9FAyCp-poCCS4_N0n6uz25mF910yZX-ZatNnxnGuZbMyVM9Z3Xhv7P-ob_OxdJQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2842356512</pqid></control><display><type>article</type><title>OC65 Blood phytosterol levels in children with intestinal failure on home parenteral nutrition, and relation to liver disease</title><source>PubMed Central Free</source><creator>Abdelhafez, H ; Gayda-Pimlott, D ; Horn, V ; Al-Araji, R ; Koeglmeier, J ; Hill, S</creator><creatorcontrib>Abdelhafez, H ; Gayda-Pimlott, D ; Horn, V ; Al-Araji, R ; Koeglmeier, J ; Hill, S</creatorcontrib><description>Intestinal failure-associated liver disease(IFALD) in children on parenteral nutrition(PN) probably has a multifactorial aetiology. In particular, soya lipid emulsion has been associated with accumulation of phytosterols and associated cholestatic liver disease.1 More recently mixed lipid emulsions which include fish, as well as soya, olive and coconut oil, &gt;vitamin E and &lt;phytosterols2 have largely replaced pure Soybean lipid.Our aim was to investigate whether patients on long-term treatment with PN at home on mixed lipid emulsions such as SMOF(soya, MCT, olive, fish oil)lipid have raised phytosterol blood levels and IFALD.Retrospective Data was collected from our hospital’s electronic patient records for all patients on home PN in 2022 for &gt;6 months. Data collected included: age, gender, diagnosis (categorised as short bowel syndrome[SBS], motility disorder or intestinal mucosal disorder), years on PN, nights/week PN infused, nights/week with lipid, whether tolerating some oral/enteral nutrition and liver US. Blood results reviewed were phytosterol, albumin, liver enzyme(ALT, ALP, GGT), Vitamin A, E, D, clotting screen, and platelet levels.There were 29 children,16 female,13 male, aged 2–18 years. Eleven, 38%, had SBS, 9, 31% motility disorder and 9, 31% a mucosal disorder. Twenty-three, 79% tolerated some oral/enteral nutrition and 6, 21% did not.Eighteen patients, 62% were on PN since infancy. Patients had 3–7(mean 6.3) PN infusions/week, administered over 10–24(mean 13.5)hours, with lipid included from 0–5(mean 2.6) nights/week. The lipid used was SMOFlipid.Three patients, 10.3% had mildly elevated phytosterol levels, three, 10.3% borderline raised levels (within 10% of normal range) and 23, 79.3% had normal levels. One child on anti-fungal medication had a raised fungal related sterol, lanosterol. The elevated phytosterols in the three patients were:1. mild elevation of whole phytosterol profile2. raised Sitosterol and a cholesterol precursor level3. raised SitosterolTwo patients with high phytosterol levels had low blood albumen, 28g/l. Albumin was normal in the other 27 patients. ALT was normal in 27/29 patients and raised in 2/29(range 9–138U/L, median 28 U/L). Bilirubin was normal/borderline raised in all cases ranging from 2–20(median 8)umol/l. GGT ranged from 10–14(median 22) U/L. ALP ranged from 95–324U/L, median 202U/l. Vitamin A levels were 0.62–2.13(median 1.37) umol/L, Vitamin E was normal 11.5–46.4 umol/L in all 29 cases. Vitamin D was 33–122(median 68)nmol/L. Coagulation was normal in 20 patients and prolonged in 9 on anticoagulant treatment. Platelet levels were 52–444(median 233) x109/l. One patient had hepatic steatosis on U/S with with normal phytosterols and liver function tests.In summary, children on long-term home PN on mixed lipid infusions had normal or only borderline raised phytosterol and liver function tests. In conclusion, phytosterol levels are not usually raised in children on PN with mixed lipid formulations and IFALD does not appear to be a problem. Clayton P, Bowron A, Mills K, et al. Phytosterolaemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology 1993;105:1806–1813. Lapillonne A, Mis N, Goulet O, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on paediatric parenteral nutrition: Lipids. Clinical Nutrition 2018;37:2324–2336.</description><identifier>ISSN: 2041-4137</identifier><identifier>EISSN: 2041-4145</identifier><identifier>DOI: 10.1136/flgastro-2023-bspghan.64</identifier><language>eng</language><publisher>London: BMJ Publishing Group LTD</publisher><subject>Enteral nutrition ; Lipids ; Liver diseases ; Motility ; Nutrition ; Parenteral nutrition ; Patients ; Vitamin E</subject><ispartof>Frontline gastroenterology, 2023-07, Vol.14 (Suppl 1), p.A40-A40</ispartof><rights>2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Abdelhafez, H</creatorcontrib><creatorcontrib>Gayda-Pimlott, D</creatorcontrib><creatorcontrib>Horn, V</creatorcontrib><creatorcontrib>Al-Araji, R</creatorcontrib><creatorcontrib>Koeglmeier, J</creatorcontrib><creatorcontrib>Hill, S</creatorcontrib><title>OC65 Blood phytosterol levels in children with intestinal failure on home parenteral nutrition, and relation to liver disease</title><title>Frontline gastroenterology</title><description>Intestinal failure-associated liver disease(IFALD) in children on parenteral nutrition(PN) probably has a multifactorial aetiology. In particular, soya lipid emulsion has been associated with accumulation of phytosterols and associated cholestatic liver disease.1 More recently mixed lipid emulsions which include fish, as well as soya, olive and coconut oil, &gt;vitamin E and &lt;phytosterols2 have largely replaced pure Soybean lipid.Our aim was to investigate whether patients on long-term treatment with PN at home on mixed lipid emulsions such as SMOF(soya, MCT, olive, fish oil)lipid have raised phytosterol blood levels and IFALD.Retrospective Data was collected from our hospital’s electronic patient records for all patients on home PN in 2022 for &gt;6 months. Data collected included: age, gender, diagnosis (categorised as short bowel syndrome[SBS], motility disorder or intestinal mucosal disorder), years on PN, nights/week PN infused, nights/week with lipid, whether tolerating some oral/enteral nutrition and liver US. Blood results reviewed were phytosterol, albumin, liver enzyme(ALT, ALP, GGT), Vitamin A, E, D, clotting screen, and platelet levels.There were 29 children,16 female,13 male, aged 2–18 years. Eleven, 38%, had SBS, 9, 31% motility disorder and 9, 31% a mucosal disorder. Twenty-three, 79% tolerated some oral/enteral nutrition and 6, 21% did not.Eighteen patients, 62% were on PN since infancy. Patients had 3–7(mean 6.3) PN infusions/week, administered over 10–24(mean 13.5)hours, with lipid included from 0–5(mean 2.6) nights/week. The lipid used was SMOFlipid.Three patients, 10.3% had mildly elevated phytosterol levels, three, 10.3% borderline raised levels (within 10% of normal range) and 23, 79.3% had normal levels. One child on anti-fungal medication had a raised fungal related sterol, lanosterol. The elevated phytosterols in the three patients were:1. mild elevation of whole phytosterol profile2. raised Sitosterol and a cholesterol precursor level3. raised SitosterolTwo patients with high phytosterol levels had low blood albumen, 28g/l. Albumin was normal in the other 27 patients. ALT was normal in 27/29 patients and raised in 2/29(range 9–138U/L, median 28 U/L). Bilirubin was normal/borderline raised in all cases ranging from 2–20(median 8)umol/l. GGT ranged from 10–14(median 22) U/L. ALP ranged from 95–324U/L, median 202U/l. Vitamin A levels were 0.62–2.13(median 1.37) umol/L, Vitamin E was normal 11.5–46.4 umol/L in all 29 cases. Vitamin D was 33–122(median 68)nmol/L. Coagulation was normal in 20 patients and prolonged in 9 on anticoagulant treatment. Platelet levels were 52–444(median 233) x109/l. One patient had hepatic steatosis on U/S with with normal phytosterols and liver function tests.In summary, children on long-term home PN on mixed lipid infusions had normal or only borderline raised phytosterol and liver function tests. In conclusion, phytosterol levels are not usually raised in children on PN with mixed lipid formulations and IFALD does not appear to be a problem. Clayton P, Bowron A, Mills K, et al. Phytosterolaemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology 1993;105:1806–1813. Lapillonne A, Mis N, Goulet O, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on paediatric parenteral nutrition: Lipids. Clinical Nutrition 2018;37:2324–2336.</description><subject>Enteral nutrition</subject><subject>Lipids</subject><subject>Liver diseases</subject><subject>Motility</subject><subject>Nutrition</subject><subject>Parenteral nutrition</subject><subject>Patients</subject><subject>Vitamin E</subject><issn>2041-4137</issn><issn>2041-4145</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqNjb1OBDEMhCMEEie4d7BEyx6bv4WaE4iOhv4UWO9tTiZe4uwhKmh4UZ6EICFq3Njj-UajFOh2pbXtLgbaBimZG9Ma2zzKtB1DWnXuQC1M63TjtPOHf7e9PFZLkV1bx1rtvVuo9_t1578-Pq-JuYdpfCssBTMTEO6RBGKCpzFSnzHBayxjfRSUElMgGEKkOSNwgpGfEaZQqZquVppLjiVyOoeQeshI4UdBYaC4xwx9FAyCp-poCCS4_N0n6uz25mF910yZX-ZatNnxnGuZbMyVM9Z3Xhv7P-ob_OxdJQ</recordid><startdate>20230701</startdate><enddate>20230701</enddate><creator>Abdelhafez, H</creator><creator>Gayda-Pimlott, D</creator><creator>Horn, V</creator><creator>Al-Araji, R</creator><creator>Koeglmeier, J</creator><creator>Hill, S</creator><general>BMJ Publishing Group LTD</general><scope>K9.</scope></search><sort><creationdate>20230701</creationdate><title>OC65 Blood phytosterol levels in children with intestinal failure on home parenteral nutrition, and relation to liver disease</title><author>Abdelhafez, H ; Gayda-Pimlott, D ; Horn, V ; Al-Araji, R ; Koeglmeier, J ; Hill, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_28423565123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Enteral nutrition</topic><topic>Lipids</topic><topic>Liver diseases</topic><topic>Motility</topic><topic>Nutrition</topic><topic>Parenteral nutrition</topic><topic>Patients</topic><topic>Vitamin E</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abdelhafez, H</creatorcontrib><creatorcontrib>Gayda-Pimlott, D</creatorcontrib><creatorcontrib>Horn, V</creatorcontrib><creatorcontrib>Al-Araji, R</creatorcontrib><creatorcontrib>Koeglmeier, J</creatorcontrib><creatorcontrib>Hill, S</creatorcontrib><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>Frontline gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abdelhafez, H</au><au>Gayda-Pimlott, D</au><au>Horn, V</au><au>Al-Araji, R</au><au>Koeglmeier, J</au><au>Hill, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>OC65 Blood phytosterol levels in children with intestinal failure on home parenteral nutrition, and relation to liver disease</atitle><jtitle>Frontline gastroenterology</jtitle><date>2023-07-01</date><risdate>2023</risdate><volume>14</volume><issue>Suppl 1</issue><spage>A40</spage><epage>A40</epage><pages>A40-A40</pages><issn>2041-4137</issn><eissn>2041-4145</eissn><abstract>Intestinal failure-associated liver disease(IFALD) in children on parenteral nutrition(PN) probably has a multifactorial aetiology. In particular, soya lipid emulsion has been associated with accumulation of phytosterols and associated cholestatic liver disease.1 More recently mixed lipid emulsions which include fish, as well as soya, olive and coconut oil, &gt;vitamin E and &lt;phytosterols2 have largely replaced pure Soybean lipid.Our aim was to investigate whether patients on long-term treatment with PN at home on mixed lipid emulsions such as SMOF(soya, MCT, olive, fish oil)lipid have raised phytosterol blood levels and IFALD.Retrospective Data was collected from our hospital’s electronic patient records for all patients on home PN in 2022 for &gt;6 months. Data collected included: age, gender, diagnosis (categorised as short bowel syndrome[SBS], motility disorder or intestinal mucosal disorder), years on PN, nights/week PN infused, nights/week with lipid, whether tolerating some oral/enteral nutrition and liver US. Blood results reviewed were phytosterol, albumin, liver enzyme(ALT, ALP, GGT), Vitamin A, E, D, clotting screen, and platelet levels.There were 29 children,16 female,13 male, aged 2–18 years. Eleven, 38%, had SBS, 9, 31% motility disorder and 9, 31% a mucosal disorder. Twenty-three, 79% tolerated some oral/enteral nutrition and 6, 21% did not.Eighteen patients, 62% were on PN since infancy. Patients had 3–7(mean 6.3) PN infusions/week, administered over 10–24(mean 13.5)hours, with lipid included from 0–5(mean 2.6) nights/week. The lipid used was SMOFlipid.Three patients, 10.3% had mildly elevated phytosterol levels, three, 10.3% borderline raised levels (within 10% of normal range) and 23, 79.3% had normal levels. One child on anti-fungal medication had a raised fungal related sterol, lanosterol. The elevated phytosterols in the three patients were:1. mild elevation of whole phytosterol profile2. raised Sitosterol and a cholesterol precursor level3. raised SitosterolTwo patients with high phytosterol levels had low blood albumen, 28g/l. Albumin was normal in the other 27 patients. ALT was normal in 27/29 patients and raised in 2/29(range 9–138U/L, median 28 U/L). Bilirubin was normal/borderline raised in all cases ranging from 2–20(median 8)umol/l. GGT ranged from 10–14(median 22) U/L. ALP ranged from 95–324U/L, median 202U/l. Vitamin A levels were 0.62–2.13(median 1.37) umol/L, Vitamin E was normal 11.5–46.4 umol/L in all 29 cases. Vitamin D was 33–122(median 68)nmol/L. Coagulation was normal in 20 patients and prolonged in 9 on anticoagulant treatment. Platelet levels were 52–444(median 233) x109/l. One patient had hepatic steatosis on U/S with with normal phytosterols and liver function tests.In summary, children on long-term home PN on mixed lipid infusions had normal or only borderline raised phytosterol and liver function tests. In conclusion, phytosterol levels are not usually raised in children on PN with mixed lipid formulations and IFALD does not appear to be a problem. Clayton P, Bowron A, Mills K, et al. Phytosterolaemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology 1993;105:1806–1813. Lapillonne A, Mis N, Goulet O, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on paediatric parenteral nutrition: Lipids. Clinical Nutrition 2018;37:2324–2336.</abstract><cop>London</cop><pub>BMJ Publishing Group LTD</pub><doi>10.1136/flgastro-2023-bspghan.64</doi></addata></record>
fulltext fulltext
identifier ISSN: 2041-4137
ispartof Frontline gastroenterology, 2023-07, Vol.14 (Suppl 1), p.A40-A40
issn 2041-4137
2041-4145
language eng
recordid cdi_proquest_journals_2842356512
source PubMed Central Free
subjects Enteral nutrition
Lipids
Liver diseases
Motility
Nutrition
Parenteral nutrition
Patients
Vitamin E
title OC65 Blood phytosterol levels in children with intestinal failure on home parenteral nutrition, and relation to liver disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T06%3A46%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=OC65%E2%80%85Blood%20phytosterol%20levels%20in%20children%20with%20intestinal%20failure%20on%20home%20parenteral%20nutrition,%20and%20relation%20to%20liver%20disease&rft.jtitle=Frontline%20gastroenterology&rft.au=Abdelhafez,%20H&rft.date=2023-07-01&rft.volume=14&rft.issue=Suppl%201&rft.spage=A40&rft.epage=A40&rft.pages=A40-A40&rft.issn=2041-4137&rft.eissn=2041-4145&rft_id=info:doi/10.1136/flgastro-2023-bspghan.64&rft_dat=%3Cproquest%3E2842356512%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_28423565123%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2842356512&rft_id=info:pmid/&rfr_iscdi=true